Clinical, regulatory and pharmacovigilance solution provider
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
54
NCT05353686
A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes
Phase: Phase 2
Role: Collaborator
Start: Feb 25, 2019
Completion: Dec 19, 2019
Loading map...